Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract

International Journal of Urology

Volumn 9, Issue 12, 2002, Pages 677-680

  Miyake, Hideaki ^a   Eto, Hiroshi ^a   Hara, Shoji ^b   Okada, Hiroshi ^b   Kamidono, Sadao ^b   Hara, Isao ^b  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacillus Calmette Gu rin; Carcinoma in situ; Upper urinary tract

Indexed keywords

BCG VACCINE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BLADDER IRRITATION; CANCER LOCALIZATION; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTECTOMY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; HUMAN; MALE; NEPHROURETERECTOMY; PERCUTANEOUS NEPHROSTOMY; PRIORITY JOURNAL; RECURRENT CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URETER CATHETERIZATION; URETER STENT; URINALYSIS; URINARY TRACT CARCINOMA;

EID: 0037231588     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00551.x     Document Type: Article

References (14)

1. Alexandroff AB, Jackson AM, O'Donnell MA et al. BCG immunotherapy of bladder cancer 20 years on. Lancet 1999; 353: 1689-94.
2. Mungan NA, Witjes JA. Bacillus Calmette-Guérin in superficial transitional cell carcinoma. Br. J. Urol. 1998; 82: 213-23.
3. Herr HW. Durable response of a carcinoma in situ of the renal pelvis to topic bacillus Calmette-Guérin. J. Urol. 1985; 134: 531-2.
4. Studer UE, Casanova G, Kraft R et al. Percutaneous bacillus Calmette-Guérin perfusion of the upper urinary tract for carcinoma in situ. J. Urol. 1989; 142: 975-7.
5. Ramsey JC, Soloway MS. Instillation of bacillus Calmette-Guérin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. J. Urol. 1990; 143: 1220-2.
6. Mukamel E, Vilkovsky E, Hadar H et al. The effect of intravesical bacillus Calmette-Guérin therapy on the upper urinary tract. J. Urol. 1991; 146: 700-3.
7. Schoenberg MP, van Arsdalen KN, Wein AJ. The management of transitional cell carcinoma in solitary renal units. J. Urol. 1993; 149: 457-60.
8. Sharpe JR, Duffy G, Chin JL. Intrarenal bacillus Calmette-Guérin therapy for upper urinary tract carcinoma in situ. J. Urol. 1993; 149: 457-60.
9. Yokogi H, Wada Y, Mizutani N et al. Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. Br. J. Urol. 1996; 77: 676-9.
10. Nonomura N, Ono Y, Nozawa M et al. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur. Urol. 2000; 38: 701-5.
11. Nishino Y, Yamamoto N, Komeda H et al. Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract. BJU Int. 2000; 85: 799-801.
12. Okubo K, Ichioka N, Terada Y et al. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in case of failure. BJU Int. 2001; 88: 343-7.
13. Yamashita S, Kanetake H, Saito Y et al. Management of upper urinary tract carcinoma in situ. Nishinihon J. Urol. 1994; 56: 642-6.
14. Mori H, Miyaji B, Takahashi M et al. Intracavitary bacillus Calmette-Guérin therapy for upper tract transitional cell carcinoma. Acta Urol. Jpn. 1996; 42: 257-61.